Research Article
Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells
Table 1
Details of 10 SLE patients.
| Patient | Age | Disease duration | Current treated | SLEDAI |
| 1 | 21 | 1 year | Pred 15mg/day | 10 | | | | HCQ 0.2g/day | | 2 | 18 | 9 months | Pred 15mg/day | 14 | | | | HCQ 0.2g/day | | | | | LEF 0.2g/day | | 3 | 24 | 2 years | Pred 15mg/day | 9 | | | | HCQ 0.2g/day | | 4 | 28 | 1 year | Pred 15mg/day | 12 | | | | HCQ 0.2g/day | | 5 | 24 | 2 years | Pred 10mg/day | 14 | | | | HCQ 0.2g/day | | | | | CTX 0.4g/2 weeks | | 6 | 32 | 3 years | Pred 15mg/day | 12 | | | | HCQ 0.2g/day | | 7 | 43 | 6 years | Pred 10mg/day | 9 | | | | HCQ 0.2g/day | | 8 | 21 | 4 days | none | 13 | 9 | 26 | 1 month | Pred 12.5mg/day | 14 | HCQ 0.2g/day | 10 | 32 | 1 year | Pred 20mg/day | 21 | | | | HCQ 0.2g/day | | | | | CTX 0.4g/2 weeks | |
|
|
Pred: prednisolone, HCQ: hydroxychloroquine. LEF: leflunomide, CTX: cyclophosphamide.
|